Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT05381883

Mental Health of Professionals of the Silver Economy of New Aquitaine : Online Survey of Accommodation Establishments for Old People and Home Assistance Establishments

The purpose of this study is identify the psychological impact of the coronavirus-19 pandemic on professionals in residential care facilities for old people and home help professionals in New-Aquitaine by :

1. Large-scale screening for the prevalence of mental health disorders among staff. 2. Identification of vulnerability and resilience factors. 3. Improving access to early care for affected professionals.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

This is a repeated cross-sectional descriptive study with two independent collection points six months apart, using socio-economic self-questionnaires and psychometric scales, which aims to measure the incidence of psychological disorders.

This study included the completion of questionnaires in a non-clinical population. This is a study aimed at describing a profile of psychological condition in adults.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be aged 18 and over,
  • Have given their consent to participate in the study,
  • Work in an accommodation establishment for the elderly or professional home help in New Aquitaine.
  • Master the French language.
  • Accept online reviews
  • Be a beneficiary of health insurance

Exclusion criteria

  • Bad understanding of instructions making consent or assessment impossible
  • Refusal to participate
  • Be under measure of legal protection: guardianship, trusteeship or safeguard of justice

Treatment and study plan

Questionnaire

Other

Participants will answer socio-demographic questions, questions about the lifetime experience of potentially traumatic events, the presence of a known psychological or medical disorder and the taking of medication, and a series of psychological assessment questionnaires.

The questionnaires, performed outside routine care, are as follows :

Posttraumatic stress disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders-5 Beck Depression Inventory-Fast Screen General Anxiety Disorder-7 Coping Inventory for Stressful Situations Maslach Burnout Inventory Medical Outcomes Study Short-Form

The total time for completing the questionnaires is estimated at 20 minutes

Primary outcomes

  1. Prevalence of anxiety disorders

    Time frame: Baseline

    The appearance of symptoms of anxiety disorders measured through the General Anxiety Disorder-7 questionnaire A total score greater than 7 should lead to the hypothesis of a generalized anxiety disorder. A total score between 5 and 9 corresponds to mild anxiety, a score of 10 to 14 corresponds to moderate anxiety and a score above 15 corresponds to severe anxiety.

  2. Prevalence of anxiety disorders

    Time frame: Baseline

    The appearance of symptoms of anxiety disorders measured through the Panic Disorder Self-Report questionnaire. This questionnaire is a 24-item self-report measure designed to diagnose panic disorder based on Diagnostic and Statistical Manual-IV and Diagnostic and Statistical Manual-V criteria.

    Most of items are answered in a simple Yes/No fashion. Nevertheless, there are also some questions, for example about severity, which are answered on 5-point Likert scales. Not all of the questions have to be answered by every patient. If a panic disorder can already be excluded, the questionnaire stops.

Secondary outcomes

  1. Measure the prevalence of post-traumatic stress disorder

    Time frame: Baseline

    Participants will answer the Posttraumatic stress disorder Checklist which is a questionnaire allowing the screening of post-traumatic stress disorder.

    Min=0 max=80 Higher score mean a worse outcome

  2. Measure the prevalence of depressive episodes

    Time frame: Baseline

    Participants will answer the Beck Depression Inventory- Fast Screen which is the questionnaire for screening for major depressive disorder Min = 0 Max =21 Higher score mean a worse outcome

  3. Measure the prevalence of depressive episodes

    Time frame: Baseline

    Participants will answer the Coping Inventory for Stressful Situations which is the scale assesses the 4 types of coping strategies (emotion-focused, support-focused, problem-focused, avoidance-focused ).

    There are three sub-scales :

    Task oriented min=0 max=56 Emotional oriented min=0 max =42 Avoidance oreinted min =0 max =51

  4. Study the professional burnout syndrome

    Time frame: Baseline

    Participants will answer the Maslach Burnout Inventory which is the questionnaire allowing the screening of a burn-out.

    There are three sub-scales :

    Burnout score min =0 max =54 Depersonalization score / Loss of empathy min =0 max=30 For these two subscales: Higher scores mean a worse outcome Personal Achievement Score min = 0 max=48 For this subscale: Higher score mean a better outcome

  5. Study the the quality of life at work among staff

    Time frame: Baseline

    Participants will answer the Medical Outcomes Study Short-Form which is the questionnaire to assess the quality of life Min=0 max=100 Higher score mean a better outcome

  6. Study the use of psychostimulant substances (drugs, alcohol, drugs, tobacco) among the staff of accommodation facilities for old people and home help

    Time frame: Baseline

    The consumption of psychoactive substances will be assessed through a multiple-choice menu, allowing to tick the substances consumed by the participant during the last month. The categories of psychoactive substances are: anxiolytics and sedatives (eg benzodiazepines, hypnotics etc), psycho-stimulants (eg cocaine, amphetamines, ecstasy etc), opiates and related drugs (eg codeine, heroin etc), cannabis, alcohol and tobacco. According to the items, the person will indicate for each psychoactive substance checked the level of consumption (absent, new, increasing, constant).

Study contacts

Contact information is provided by the study sponsor or research team.

Charles-Henry MARTIN, MD

CONTACT

[email protected]

05 56 56 31 30

Helen SAVARIEAU

CONTACT

[email protected]

05 56 56 35 56

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Charles Perrens, Bordeaux

Other Gov

Registry information

Acronym: SILVER NA

Important dates

Study start
2024
Primary completion
2024
Study completion
2026
First posted
May 19, 2022
Registry last updated
Jun 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.